At Reuters Pharma USA in March, ZS Associates' Maria Whitman sat down with pharmaphorum to discuss why it's time to reinvent pharma's marketing strategy
As Pear Therapeutics’ financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on the road for digital therapeutics, or a sign of d